查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886125

全球感染疾病診斷市場

Infectious Disease Diagnostics
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 259 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到2030年，全球感染疾病診斷市場規模將達457億美元。

全球感染疾病診斷市場預計在2024年達到331億美元，到2030年將達到457億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為5.5%。本報告分析的細分市場之一「檢測和試劑」預計將以4.9%的複合年成長率成長，並在分析期結束時達到258億美元。 「儀器」細分市場預計在分析期間將以6.5%的複合年成長率成長。

美國市場規模估計為87億美元，而中國市場預計將以8.2%的複合年成長率成長。

預計到2024年，美國感染疾病診斷市場規模將達87億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到102億美元，在2024年至2030年的分析期間內，複合年成長率（CAGR）為8.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為2.9%和5.1%。在歐洲，德國的複合年成長率預計約為3.3%。

感染疾病診斷市場－主要市場趨勢與促進因素概述

什麼是感染疾病診斷？它對公共衛生為何如此重要？

感染疾病診斷是指用於識別人體檢體中病原體（例如細菌、病毒、真菌和寄生蟲）的檢測和程序。這些診斷技術是公共衛生的基石，因為它們能夠早期發現、診斷和控制感染疾病，從而防止疾病傳播，降低發病率和死亡率。這些技術包括傳統的培養技術、血清學檢測以及先進的分子方法，例如聚合酵素鏈鎖反應(PCR) 和次世代定序。在集體爆發的情況下，例如新冠肺炎 (COVID-19) 大流行，這些工具至關重要，因為快速識別和隔離病例是關鍵。生物醫學的進步不斷提高診斷的有效性，從而實現更準確、更快速、更經濟的檢測。

科技進步如何改變感染疾病診斷格局？

感染疾病診斷領域正因重大的技術進步而重塑。諸如照護現場（POC​​）設備等創新技術無需專業實驗室即可實現快速現場診斷，從而促進了偏遠和資源匱乏地區疾病的診斷。此外，數位健康技術的整合，包括能夠即時追蹤疾病爆發的健康資訊系統，正在提高疾病監測和應對的效率。分子診斷技術，特別是基於PCR和CRISPR的診斷技術，透過實現對病原體的高靈敏度和特異性檢測，徹底革新了這個領域。這些進步不僅增強了診斷能力，還促進了個人化治療治療方法能夠根據診斷結果，針對每位患者的個別需求量身定做。

哪些全球趨勢正在影響感染疾病診斷市場？

影響感染疾病診斷市場的全球趨勢包括感染疾病率的上升以及結核病和瘧疾等疾病的復發。都市化和國際旅行的活性化加劇了感染疾病的快速傳播，凸顯了對有效診斷工具的需求。氣候變遷也是一個重要因素，氣溫和降水模式的變化影響媒介傳播感染疾病的分佈，並增加了診斷需求。此外，日益嚴重的抗菌素抗藥性推動了能夠快速識別抗藥性病原體並指導合理治療決策的診斷方法的發展。這些趨勢要求開發強大且擴充性的診斷解決方案，以便在全球部署，從而應對地方性流行和新興感染疾病。

感染疾病診斷市場的成長受多種因素驅動。

感染疾病診斷市場的成長受多種因素驅動，包括技術創新、流行病學變化以及醫療基礎設施的完善。能夠提供更快、更準確、更經濟高效的診斷檢測的技術進步對於有效控制疫情和地方性疾病至關重要。國際旅行增加和都市化等因素導致全球感染疾病負擔日益加重，這也對推動先進診斷技術的需求起到了關鍵作用。此外，政府和醫療機構重視預防保健和早期診斷的政策也顯著促進了市場擴張。對醫療基礎設施的投資，尤其是在發展中地區，提高了診斷服務的可近性，進一步推動了市場成長。消費行為，特別是新冠疫情后人們對健康和預防措施意識的提高，持續推動這些診斷技術在日常醫療實踐中的應用。這些因素共同反映了全球醫療保健策略向更積極主動的預防性策略轉變，並支持感染疾病診斷市場的蓬勃發展。

部分：

產品（檢測/試劑、設備、軟體）技術（免疫診斷、臨床微生物、PCR、INAAT、DNA定序/NGS、DNA微陣列及其他技術）

受訪公司範例

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Roche Diagnostics（Schweiz）AG
  • Siemens AG
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有採用查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括視訊文字稿、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP12706

Global Infectious Disease Diagnostics Market to Reach US$45.7 Billion by 2030

The global market for Infectious Disease Diagnostics estimated at US$33.1 Billion in the year 2024, is expected to reach US$45.7 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.7 Billion While China is Forecast to Grow at 8.2% CAGR

The Infectious Disease Diagnostics market in the U.S. is estimated at US$8.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.2 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Infectious Disease Diagnostics Market - Key Trends & Drivers Summarized

What Are Infectious Disease Diagnostics and Why Are They Fundamental to Public Health?

Infectious disease diagnostics comprise tests and procedures used to identify the presence of pathogens like bacteria, viruses, fungi, or parasites in human samples. These diagnostics are fundamental to public health as they enable early detection, diagnosis, and management of infections, thereby preventing their spread and reducing morbidity and mortality. Technologies utilized include traditional culture techniques, serological assays, and advanced molecular methods like polymerase chain reaction (PCR) and next-generation sequencing. These tools are vital in outbreak situations, such as the COVID-19 pandemic, where rapid identification and isolation of cases are critical. The effectiveness of diagnostics is continually enhanced by advancements in biomedical science, contributing to more accurate, faster, and cost-effective tests.

How Is Technological Advancement Shaping the Landscape of Infectious Disease Diagnostics?

The landscape of infectious disease diagnostics is being reshaped by significant technological advancements. Innovations such as point-of-care (POC) testing devices allow for rapid, on-site diagnosis without the need for specialized laboratory facilities, making it easier to diagnose diseases in remote or resource-limited settings. Additionally, the integration of digital health technologies, including health information systems that track disease outbreaks in real time, is improving the efficiency of disease surveillance and response. Molecular diagnostic techniques, particularly PCR and CRISPR-based diagnostics, have revolutionized the field by providing high sensitivity and specificity in detecting pathogens. These advancements not only enhance diagnostic capabilities but also facilitate personalized treatment approaches, tailoring interventions to individual patient needs based on diagnostic results.

What Global Trends Are Influencing the Infectious Disease Diagnostics Market?

Several global trends are influencing the infectious disease diagnostics market, notably the increasing incidence of infectious diseases and the resurgence of conditions such as tuberculosis and malaria. Urbanization and global travel contribute to the rapid spread of infections, highlighting the need for effective diagnostic tools. Climate change also plays a role, as changing temperatures and precipitation patterns affect the distribution of vector-borne diseases, increasing the demand for diagnostics. Furthermore, the rise in antimicrobial resistance is prompting the development of diagnostics that can quickly identify resistant pathogens and guide appropriate treatment decisions. These trends necessitate robust, scalable diagnostic solutions that can be deployed globally to manage both endemic diseases and emerging infections.

Growth in the Infectious Disease Diagnostics Market Is Driven by Several Factors

The growth in the infectious disease diagnostics market is driven by several factors, including technological innovations, epidemiological shifts, and healthcare infrastructure developments. Technological advances that offer quicker, more accurate, and cost-effective diagnostic tests are crucial, as they improve the capacity to manage outbreaks and endemic diseases effectively. The increasing global burden of infectious diseases, driven by factors such as increased international travel and urbanization, also plays a significant role in fueling the demand for advanced diagnostics. Additionally, government and healthcare policies focusing on preventive care and early diagnosis are significantly influencing market expansion. Investments in healthcare infrastructure, particularly in developing regions, are enabling wider access to diagnostic services, further propelling market growth. Consumer behavior, especially heightened awareness regarding health and preventive measures following the COVID-19 pandemic, continues to drive the adoption of these diagnostics in routine healthcare practices. These combined factors underscore the dynamic expansion of the infectious disease diagnostics market, reflecting a global shift towards more proactive and preventive healthcare strategies.

SCOPE OF STUDY:

The report analyzes the Infectious Disease Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Assays & Reagents, Instruments, Software); Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray, Other Technologies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 213 Featured) -

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Roche Diagnostics (Schweiz) AG
  • Siemens AG
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Infectious Disease Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Infectious Diseases Spurs Demand for Advanced Diagnostic Solutions
    • Advancements in Molecular Diagnostics Propel Growth in Infectious Disease Testing
    • COVID-19 Pandemic Throws the Spotlight on Importance of Rapid and Point-of-Care Diagnostics
    • Increasing Focus on Early Detection and Prevention Expands Addressable Market for Infectious Disease Diagnostics
    • Growing Need for Accurate and Rapid Diagnostic Results Strengthens Business Case for Innovative Technologies
    • Emergence of Multiplex Diagnostic Platforms Generates Opportunities for Comprehensive Disease Screening
    • The Role of Artificial Intelligence and Machine Learning in Enhancing Diagnostic Accuracy Sustains Market Growth
    • Rising Investment in Healthcare Infrastructure in Emerging Markets Propels Demand for Infectious Disease Diagnostics
    • Increasing Consumer Awareness and Access to Testing Drives Adoption of At-Home Diagnostic Kits
    • Growing Emphasis on Personalized Medicine and Targeted Therapies Expands Use of Precision Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Immunodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Infectious Disease Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Assays & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Assays & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Assays & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinical Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinical Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinical Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for INAAT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for INAAT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for INAAT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for DNA Sequencing & NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for DNA Sequencing & NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for DNA Sequencing & NGS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for DNA Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for DNA Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for DNA Microarray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • JAPAN
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • CHINA
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • EUROPE
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Infectious Disease Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • FRANCE
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • GERMANY
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Spain 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Russia 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Infectious Disease Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Australia 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • INDIA
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: India 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: South Korea 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Infectious Disease Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Argentina 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Brazil 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Mexico 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Infectious Disease Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Iran 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Israel 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: UAE 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030
  • AFRICA
    • Infectious Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Infectious Disease Diagnostics by Technology - Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Infectious Disease Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Infectious Disease Diagnostics by Product - Assays & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Africa 15-Year Perspective for Infectious Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Assays & Reagents, Instruments and Software for the Years 2015, 2025 & 2030

IV. COMPETITION